The landscape of pharmacogenetic testing in a US managed care population

PURPOSE: Little is known about how many insured patients receive pharmacogenetic testing. We describe trends of single-gene pharmacogenetic testing in a US managed care population, and demographic and clinical characteristics of patients who received a test. METHODS: We leveraged a random sample of...

Descripción completa

Detalles Bibliográficos
Autores principales: Anderson, Heather D., Crooks, Kristy R., Kao, David P., Aquilante, Christina L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7332417/
https://www.ncbi.nlm.nih.gov/pubmed/32291400
http://dx.doi.org/10.1038/s41436-020-0788-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7332417/
https://www.ncbi.nlm.nih.gov/pubmed/32291400
http://dx.doi.org/10.1038/s41436-020-0788-3

Ejemplares similares